05:43 PM EDT, 04/03/2025 (MT Newswires) -- David Malcom Rodman, Chief Medical Officer, on April 01, 2025, sold 55,771 shares in Mineralys Therapeutics ( MLYS ) for $879,008. Following the Form 4 filing with the SEC, Rodman has control over a total of 116,704 common shares of the company, with 116,704 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1933414/000193341425000029/xslF345X05/wk-form4_1743716211.xml